COVID-19 and Venous Thromboembolism Risk
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID-19
- Venous Thromboembolism
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Retrospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This is an observational study of adult (age ?18 years) members enrolled in the Kaiser Permanente Northern California (KPNC) or Kaiser Permanente Southern California (KPSC) integrated healthcare delivery systems during the time period January 1, 2020 through December 31, 2020, (representing the firs...
This is an observational study of adult (age ?18 years) members enrolled in the Kaiser Permanente Northern California (KPNC) or Kaiser Permanente Southern California (KPSC) integrated healthcare delivery systems during the time period January 1, 2020 through December 31, 2020, (representing the first year of the Covid-19 pandemic) and diagnosed with incident Covid-19. The outcomes will be incident VTE and all-cause death, assessed through March 2021. The primary comparison will be the risk of post-hospitalization VTE between patients with Covid-19 compared with matched controls. Next, the risk of VTE associated with key patient subgroups, including by severity of Covid-19 disease, will be described.
Tracking Information
- NCT #
- NCT04569344
- Collaborators
- Kaiser Permanente
- Patient-Centered Outcomes Research Institute
- Investigators
- Principal Investigator: Margaret C Fang, MD University of California, San Francisco
Get Well Soon